Histaminergic and cholinergic neuron systems in the impairment of human thermoregulation during motion sickness

Brain Research Bulletin

Volumn 82, Issue 3-4, 2010, Pages 193-200

  Nobel, Gerard ^a   Tribukait, Arne ^a   Mekjavic, Igor B ^b   Eiken, Ola ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Acetylcholine; Histamine; Hypothermia; Motion illness; Temperature regulation

Indexed keywords

DIMENHYDRINATE; SCOPOLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; NEUROPEPTIDE; PLACEBO; SCOPOLAMINE BROMIDE;

ADULT; ARTICLE; CHOLINERGIC SYSTEM; DISEASE PREDISPOSITION; HUMAN; HUMAN EXPERIMENT; HYPOTHERMIA; MALE; MOTION SICKNESS; NEUROTRANSMISSION; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROVOCATION; RECTUM TEMPERATURE; SHIVERING; SWEATING; THERMOGENESIS; THERMOREGULATION; VASOCONSTRICTION; WATER IMMERSION; ANIMAL; BODY TEMPERATURE; DRUG EFFECTS; INDUCED HYPOTHERMIA; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANIMALS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; CHOLINERGIC ANTAGONISTS; DIMENHYDRINATE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPOTHERMIA, INDUCED; MALE; MOTION SICKNESS; NEURONS; NEUROPEPTIDES; OXYGEN CONSUMPTION; PLACEBOS; SCOPOLAMINE; YOUNG ADULT; SCOPOLAMINE HYDROBROMIDE;

EID: 77953542507     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.04.004     Document Type: Article

References (52)

1. Allolio B., Deuss U., Kaulen D., Winkelmann W. Effect of meclastine, a selective H1 receptor antagonist, upon ACTH release. Clin. Endocrinol. (Oxf) 1983, 19:239-245.
2. Aylward P.E., Floras J.S., Leimbach W.N., Abboud F.M. Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation 1986, 73:1145-1154.
3. Bles W., Bos J.E., Kruit H. Motion sickness. Curr. Opin. Neurol. 2000, 13:19-25.
4. Bohemier A. Effect of seasickness on aircrew student survivor ability after ditching in cold water. Agard Conference Proceedings 541 1993.
5. Boulant J.A. Neuronal basis of Hammel's model for set-point thermoregulation. J. Appl. Physiol. 2006, 100:1347-1354.
6. Brezenoff H.E., Lomax P. Temperature changes following microinjection of histamine into the thermoregulatory centers of the rat. Experientia 1970, 26:51-52.
7. Burgess N., Maguire E.A., O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35:625-641.
8. Cheung B., Hofer K. Coriolis-induced cutaneous blood flow increase in the forearm and calf. Brain Res. Bull. 2001, 54:609-618.
9. Clark W.G., Lipton J.M. Brain and pituitary peptides in thermoregulation. Pharmacol. Ther. 1983, 22:249-297.
10. Cortes R., Probst A., Palacios J.M. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem. Neuroscience 1984, 12:1003-1026.
11. Doubt J.T., Hsieh S.S. Additive effects of caffeine and cold water during submaximal leg exercise. Med. Sci. Sports Exerc. 1991, 23:435-442.
12. Drummer C., Stromeyer H., Riepl R.L., Konig A., Strollo F., Lang R.E., Maass H., Rocker L., Gerzer R. Hormonal changes after parabolic flight: implications on the development of motion sickness. Aviat. Space Environ. Med. 1990, 61:821-828.
13. Ehymayed H.M., Jansky L. A discrete mode of the antipyretic action of AVP, alpha-MSH and ACTH. Physiol. Res. 1992, 41:57-61.
14. Eiken O., Tipton M.J., Kolegard R., Lindborg B., Mekjavic I.B. Motion sickness decreases arterial pressure and therefore acceleration tolerance. Aviat. Space Environ. Med. 2005, 76:541-546.
15. Eversmann T., Gottsmann M., Uhlich E., Ulbrecht G., von Werder K., Scriba P.C. Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness. Aviat. Space Environ. Med. 1978, 49:53-57.
16. George J.M., Jacobowitz D.M. Localization of vasopressin in discrete areas of the rat hypothalamus. Brain Res. 1975, 93:363-366.
17. F. Golden, M., Essentials of Sea Survival, Human Kinetics, New York, 2002.
18. Golden F.S. Death after rescue from immersion in cold water. J. R. Nav. Med. Serv. 1973, 59:5-8.
19. Gordon C.R., Gonen A., Nachum Z., Doweck I., Spitzer O., Shupak A. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J. Psychopharmacol. 2001, 15:167-172.
20. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88:1183-1241.
21. Hemingway A. Cold sweating in motion sickness. Am. J. Physiol. 1944, 141:172-175.
22. Hirsch A.T., Dzau V.J., Majzoub J.A., Creager M.A. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor. J. Clin. Invest. 1989, 84:418-426.
23. Horii A., Takeda N., Mochizuki T., Okakura-Mochizuki K., Yamamoto Y., Yamatodani A., Kubo T. Vestibular modulation of the septo-hippocampal cholinergic system of rats. Acta Otolaryngol. 1995, Suppl. 520(Pt 2):395-398.
24. Inokuchi A., Liu F., Yokomitsu S., Ureshino M., Komiyama S. Effects of the antihistaminergic drugs diphenhydramine and zolantidine on vestibular-induced hypothalamic neuronal activity in the guinea pig. Eur. Arch. Otorhinolaryngol. 1999, 256(Suppl. 1):S22-S26.
25. Katsuura G., Yoshikawa K., Itoh S. Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats. Neurosci. Lett. 1983, 40:299-302.
26. Kohl R.L. Endocrine correlates of susceptibility to motion sickness. Aviat. Space Environ. Med. 1985, 56:1158-1165.
27. Kow L.M., Pfaff D.W. Responses of hypothalamic paraventricular neurons in vitro to norepinephrine and other feeding-relevant agents. Physiol. Behav. 1989, 46:265-271.
28. Leng G., Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J. Physiol. 2008, 586:5625-5632.
29. Llano G.A. Airmen Against the sea. An Analysis of Sea Survival Experiences 1955, Maxwell AFB, AL: Research Studies Institute ADTIC Publication G-104.
30. Mekjavic I.B., Tipton M.J., Gennser M., Eiken O. Motion sickness potentiates core cooling during immersion in humans. J. Physiol. 2001, 535:619-623.
31. Moravec J., Pierau F.K. Does the effect of AVP on hypothalamic neurones support its proposed role in endogenous antipyresis?. Physiol. Res. 1992, 41:89-90.
32. Nachum Z., Shupak A., Gordon C.R. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 2006, 45:543-566.
33. Nobel G., Eiken O., Tribukait A., Kölegård R., Mekjavic I.B. Motion sickness increases the risk of accidental hypothermia. Eur. J. Appl. Physiol. 2006, 98:48-55.
34. Otto B., Riepl R.L., Klosterhalfen S., Enck P. Endocrine correlates of acute nausea and vomiting. Auton. Neurosci. 2006, 129:17-21.
35. Palacios J.M., Wamsley J.K., Kuhar M.J. The distribution of histamine H1-receptors in the rat brain: an autoradiographic study. Neuroscience 1981, 6:15-37.
36. Reason J.T., Brand J.J. Motion Sickness 1975, Academic Press, London.
37. Romijn H.J., van Uum J.F., Emmering J., Goncharuk V., Buijs R.M. Colocalization of VIP with AVP in neurons of the human paraventricular, supraoptic and suprachiasmatic nucleus. Brain Res. 1999, 832:47-53.
38. Roth J., Zeisberger E., Vybiral S., Jansky L. Endogenous antipyretics: neuropeptides and glucocorticoids. Front. Biosci. 2004, 9:816-826.
39. Rowe J.W., Shelton R.L., Helderman J.H., Vestal R.E., Robertson G.L. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979, 16:729-735.
40. Rubinstein E.H., Sessler D.I. Skin-surface temperature gradients correlate with fingertip blood flow in humans. Anesthesiology 1990, 73:541-545.
41. Schlegel T.T., Brown T.E., Wood S.J., Benavides E.W., Bondar R.L., Stein F., Moradshahi P., Harm D.L., Fritsch-Yelle J.M., Low P.A. Orthostatic intolerance and motion sickness after parabolic flight. J. Appl. Physiol. 2001, 90:67-82.
42. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 1991, 71:1-51.
43. Sinha R. Effect of vestibular Coriolis reaction on respiration and blood-flow changes in man. Aerosp. Med. 1968, 39:837-844.
44. Stalla G.K., Doerr H.G., Bidlingmaier F., Sippel W.G., von Restorff W. Serum levels of eleven steroid hormones following motion sickness. Aviat. Space Environ. Med. 1985, 56:995-999.
45. Sunahara F.A., Farewell J., Mintz L., Johnson W.H. Pharmacological interventions for motion sickness: cardiovascular effects. Aviat. Space Environ. Med. 1987, 58:A270-276.
46. Takeda N., Morita M., Hasegawa S., Horii A., Kubo T., Matsunaga T. Neuropharmacology of motion sickness and emesis. A review. Acta Otolaryngol. Suppl. 1993, 501:10-15.
47. Theoharides T.C., Konstantinidou A.D. Corticotropin-releasing hormone and the blood-brain-barrier. Front. Biosci. 2007, 12:1615-1628.
48. Tribukait A., Nobel G., Mekjavic I.B., Eiken O. Effects of anti-histaminic and anti-cholinergic substances on human thermoregulation during cold provocation. Brain Res. Bull. 2010, 81:100-106.
49. Tsai C.L., Matsumura K., Nakayama T., Itowi N., Yamatodani A., Wada H. Effects of histamine on thermosensitive neurons in rat preoptic slice preparations. Neurosci. Lett. 1989, 102:297-302.
50. Wang E.T., Zhou D.R., He L.H. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness. Aviat. Space Environ. Med. 1992, 63:579-582.
51. Wang L.C., Man S.F., Belcastro A.N. Metabolic and hormonal responses in theophylline-increased cold resistance in males. J. Appl. Physiol. 1987, 63:589-596.
52. Wong B.J., Wilkins B.W., Minson C.T. H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans. J. Physiol. 2004, 560:941-948.